Supplementary File 4 from Bayesian Machine Learning Enables Identification of Transcriptional Network Disruptions Associated with Drug-Resistant Prostate Cancer

Supplementary File 4 from Bayesian Machine Learning Enables Identification of Transcriptional Network Disruptions Associated with Drug-Resistant Prostate Cancer

<p>Excel file with regulon edges and ChIP-seq enrichment scores for TraRe, GRNboost2 and ARACNE-AP</p>

Saved in:

書目詳細資料
主要作者:	Charles Blatti (15292859) (author)
其他作者:	Jesús de la Fuente (15292862) (author), Huanyao Gao (14962434) (author), Irene Marín-Goñi (15292865) (author), Zikun Chen (15292868) (author), Sihai D. Zhao (15292871) (author), Winston Tan (15035292) (author), Richard Weinshilboum (15292874) (author), Krishna R. Kalari (15099627) (author), Liewei Wang (14962464) (author), Mikel Hernaez (15292877) (author)
出版:	2025
主題:	Cancer Molecular and Cellular Biology Therapeutic Research and Development Methods and Technology Computational Methods Artificial intelligence & machine learning Drug Resistance Novel mechanisms Regulation of gene expression in drug resistance Gene Regulation Genitourinary Cancers Prostate cancer Systems Biology
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

相似書籍

Supplementary File 2 from Bayesian Machine Learning Enables Identification of Transcriptional Network Disruptions Associated with Drug-Resistant Prostate Cancer
由: Charles Blatti (15292859)
出版: (2025)

Supplementary File 3 from Bayesian Machine Learning Enables Identification of Transcriptional Network Disruptions Associated with Drug-Resistant Prostate Cancer
由: Charles Blatti (15292859)
出版: (2025)

Supplementary Table S1 from <i>RBM10</i> Loss Promotes <i>EGFR</i>-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
由: Yufang Bao (15386826)
出版: (2025)

Supplementary Table S2 from <i>RBM10</i> Loss Promotes <i>EGFR</i>-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
由: Yufang Bao (15386826)
出版: (2025)

Supplementary Table S3 from <i>RBM10</i> Loss Promotes <i>EGFR</i>-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
由: Yufang Bao (15386826)
出版: (2025)

Supplementary Table S4 from <i>RBM10</i> Loss Promotes <i>EGFR</i>-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
由: Yufang Bao (15386826)
出版: (2025)

Supplementary Table S5 from <i>RBM10</i> Loss Promotes <i>EGFR</i>-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition
由: Yufang Bao (15386826)
出版: (2025)

Data file S1 from Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness
由: Alex C.H. Liu (14961921)
出版: (2025)

Data file S2 from Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness
由: Alex C.H. Liu (14961921)
出版: (2025)

Data file S3 from Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness
由: Alex C.H. Liu (14961921)
出版: (2025)

Data file S4 from Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness
由: Alex C.H. Liu (14961921)
出版: (2025)

Data file S5 from Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness
由: Alex C.H. Liu (14961921)
出版: (2025)

Table S1 from Targeting STAT5 Signaling Overcomes Resistance to IDH Inhibitors in Acute Myeloid Leukemia through Suppression of Stemness
由: Alex C.H. Liu (14961921)
出版: (2025)

Supplementary Data from <i>N</i><sup>6</sup>-methyladenosine Modification of FZR1 mRNA Promotes Gemcitabine Resistance in Pancreatic Cancer
由: Jiachun Su (16990970)
出版: (2025)

Figure S1 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
由: Shiyi Yu (17079079)
出版: (2025)

Figure S2 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
由: Shiyi Yu (17079079)
出版: (2025)

Figure S3 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
由: Shiyi Yu (17079079)
出版: (2025)

Figure S4 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
由: Shiyi Yu (17079079)
出版: (2025)

Figure S5 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
由: Shiyi Yu (17079079)
出版: (2025)

Figure S6 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
由: Shiyi Yu (17079079)
出版: (2025)

Figure S7 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
由: Shiyi Yu (17079079)
出版: (2025)

Figure S8 from LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity
由: Shiyi Yu (17079079)
出版: (2025)

Supplementary Appendix S1 from DNA-Methylome–Based Tumor Hypoxia Classifier Identifies HPV-Negative Head and Neck Cancer Patients at Risk for Locoregional Recurrence after Primary Radiochemotherapy
由: Bouchra Tawk (15389486)
出版: (2025)

Supplementary Table from CircIPO7 Promotes Nasopharyngeal Carcinoma Metastasis and Cisplatin Chemoresistance by Facilitating YBX1 Nuclear Localization
由: Xiaohong Hong (22681698)
出版: (2025)

Figure 1 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
由: David Milewski (15050643)
出版: (2025)

Figure 2 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
由: David Milewski (15050643)
出版: (2025)

Figure 3 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
由: David Milewski (15050643)
出版: (2025)

Figure 4 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
由: David Milewski (15050643)
出版: (2025)

Figure 5 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
由: David Milewski (15050643)
出版: (2025)

Figure 6 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
由: David Milewski (15050643)
出版: (2025)

Supplementary Table S1-S3 from Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group
由: David Milewski (15050643)
出版: (2025)

الذكاء الاصطناعي في المصارف الإسلامية: الضوابط والمعايير الشرعية
由: Al-amrkani, Wijdan Jubran Yousef
出版: (2023)

Supplementary Data from SENP1 Decreases RNF168 Phase Separation to Promote DNA Damage Repair and Drug Resistance in Colon Cancer
由: Min Wei (16918572)
出版: (2025)

Supplementary Data from SENP1 Decreases RNF168 Phase Separation to Promote DNA Damage Repair and Drug Resistance in Colon Cancer
由: Min Wei (16918572)
出版: (2025)

Supplemental Figure S1 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
由: Jennifer L. Cotton (17315204)
出版: (2025)

Supplemental Figure S2 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
由: Jennifer L. Cotton (17315204)
出版: (2025)

Supplemental Figure S3 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
由: Jennifer L. Cotton (17315204)
出版: (2025)

Supplemental Figure S4 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
由: Jennifer L. Cotton (17315204)
出版: (2025)

Supplemental Figure S5 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
由: Jennifer L. Cotton (17315204)
出版: (2025)

Supplemental Figure S6 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
由: Jennifer L. Cotton (17315204)
出版: (2025)

Cannot write session to /tmp/vufind_sessions/sess_7ql432b4dis5e9s2ogrmptbprt